We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Lipoprotein Particle Size Predicts Development of Diabetes

By LabMedica International staff writers
Posted on 24 Aug 2010
Print article
The size and concentration of lipoproteins in the blood can help determine whether a patient will develop diabetes mellitus type 2.

The lipoprotein particle size and concentration can be measured by nuclear magnetic resonance (NMR) spectroscopy. This technique simultaneously quantifies the size and concentration of lipoprotein particles expressed each as an average particle size in nanometers or as lipoprotein particle concentration (in particle mol/L).

A prospective study, carried out at the Harvard Medical School, (Boston, MA, USA), followed 26,836 initially healthy women for 13 years for incident type-2 diabetes. During that time, 1,687 developed the disease. The study found that larger low-density lipoprotein (LDL) and high-density lipoprotein (HDL) particles were associated with lower risk, and smaller LDL and HDL particles were associated with higher risk of diabetes. Even in women with normal triglyceride and HDL cholesterol measured by standard tests, having smaller LDL particles imparted higher risk of diabetes.

Doctors typically look for increases in glucose and triglycerides, and decreases in HDL cholesterol, to determine if a patient is becoming prediabetic. Even before changes in glucose levels are detectable, there are significant changes in the metabolism of cholesterol and triglycerides. These standard lipid tests quantify the cholesterol or triglyceride content of lipoproteins, without providing size-specific lipoprotein particle information. NMR lipoproteins examined in individuals with insulin resistance or type-2 diabetes with small LDLs, small HDLs, and large very low-density lipoproteins (VLDLs) associated positively and large HDLs associated inversely with insulin resistance measured by the euglycemic clamp technique or the frequently sampled intravenous glucose tolerance test .

Samia Mora, M.D., of Harvard Medical School, said, "Our findings indicate for the first time that even before the onset of clinical type 2 diabetes, the size and number of the lipoprotein particles may indicate which women go on to develop future disease. This could provide an important opportunity for a woman with a normal blood glucose, but an abnormal NMR lipoprotein test result, to intervene early by following a healthy diet, losing weight, and increasing her physical activity level, all known ways to reduce her chance of developing diabetes even years before she gets a high glucose reading.” The results of the study were published in May 2010 issue of Diabetes.

Related Links:

Harvard Medical School



Gold Member
Hematology Analyzer
Swelab Lumi
Automated Blood Typing System
IH-500 NEXT
New
Urine Strips
11 Parameter Urine Strips
New
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.